Publications by authors named "Marcin Stajszczyk"

Claim this Profile
P
Psoriatic arthritis incidence and prevalence trajectory in Poland-public-payer, national-level, long-term data.
Magdalena Krajewska-Włodarczyk, Mateusz Szeląg, Bogdan Batko, Marcin Stajszczyk, Michał Orleański

Rheumatol Int· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comorbidity in incident rheumatoid arthritis: a nationwide case-control study with bidirectional follow-up.
Bogdan Batko, Mateusz Szeląg, Magdalena Krajewska-Włodarczyk, Zbigniew Żuber, Michał Orleański, Marcin Stajszczyk

Rheumatology (Oxford)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology and comorbidity of juvenile idiopathic arthritis in Poland- a nationwide study.
Zbigniew Żuber, Krzysztof Podwójcic, Mateusz Szeląg, Magdalena Krajewska-Włodarczyk, Krzysztof Batko, Marcin Stajszczyk

Pediatr Rheumatol Online J· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protocol for the development of Polish clinical guidelines for the management of patients with systemic lupus erythematosus.
Joanna Makowska, Brygida Kwiatkowska, Magdalena Krajewska-Włodarczyk, Bogdan Batko, Marcin Stajszczyk

Reumatologia· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Geographical Differences in the Safety and Efficacy of Tofacitinib Versus TNFi: A Post Hoc Analysis of ORAL Surveillance.
Bogdan Batko, Slawomir Jeka, Piotr Wiland, Agnieszka Zielińska, Maria Stopińska-Polaszewska, Marcin Stajszczyk

Rheumatol Ther· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Charting the Etanercept Journey: Tracing Cost Dynamics in Poland's Off-Patent Market from Reference Drug Rivalry to Biosimilar Monopoly.
Marcin Stajszczyk, Krzysztof Batko, Zbigniew Michał Żuber, Brygida Kwiatkowska, Magdalena Krajewska-Włodarczyk

BioDrugs· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Access to biologics and Janus kinase inhibitors for treatment of rheumatic diseases in the biosimilars era in Poland: a nation-level study.
Marcin Stajszczyk, Brygida Kwiatkowska, Zbigniew M Żuber, Bogdan Batko

Pol Arch Intern Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 prophylaxis, diagnostics, and treatment in patients with rheumatic diseases. The Polish experts panel opinion.
Brygida Kwiatkowska, Magdalena Krajewska-Włodarczyk, Bogdan Batko, Maria Maślińska, Marcin Stajszczyk

Reumatologia· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter evaluation of tofacitinib retention and safety in rheumatoid arthritis - why cardiovascular risk factors do not equate to overt risk.
Anna Felis-Giemza, Mateusz Moskal, Krzysztof Proc, Zbigniew Guzera, Marcin Stajszczyk

Reumatologia· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The perspective of Polish patients with rheumatoid arthritis - treatment expectations, patient-reported outcomes, and digital literacy (the SENSE study).
Marcin Stajszczyk, Grażyna Świerkowska, Katarzyna Smolik, Izabela Domysławska, Karol Charkiewicz

Reumatologia· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Budget impact analysis and treatment availability with biosimilar TNF inhibitors in rheumatic diseases in Poland: real-world evidence using a nationwide database.
Marcin Stajszczyk, Izabela Obarska, Slawomir Jeka, Bogdan Batko

Ann Rheum Dis· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep dive into achieving the therapeutic target: results from a prospective, 6‑month, observational study nested in routine rheumatoid arthritis care.
Bogdan Batko, Sławomir Jeka, Piotr Wiland, Marek Brzosko, Włodzimierz Samborski, Marcin Stajszczyk

Pol Arch Intern Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tocilizumab as a first-line biologic treatment in rheumatoid arthritis patients - the impact of concomitant methotrexate treatment and Rheumatic Disease Comorbidity Index on the clinical response - results from the multicenter observational ACT-POL study.
Marcin Stajszczyk, Sławomir Jeka, Anna Juś, Katarzyna Pawlak-Buś

Reumatologia· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Data from a Multi-Center Study: Insights to Psoriatic Arthritis Care.
Bogdan Batko, Eugeniusz Kucharz, Marcin Stajszczyk, Marek Brzosko, Włodzimierz Samborski

J Clin Med· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comorbidity burden and clinical characteristics of patients with difficult-to-control rheumatoid arthritis.
Bogdan Batko, Karol Urbański, Jerzy Świerkot, Piotr Wiland, Filip Raciborski, Marcin Stajszczyk

Clin Rheumatol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and clinical characteristics of rheumatoid arthritis in Poland: a nationwide study.
Bogdan Batko, Marcin Stajszczyk, Jerzy Świerkot, Karol Urbański, Filip Raciborski

Arch Med Sci· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tofacitinib in the treatment of patients with rheumatoid arthritis: position statement of experts of the Polish Society for Rheumatology.
Eugeniusz J Kucharz, Marcin Stajszczyk, Anna Kotulska-Kucharz, Bogdan Batko, Marek Brzosko

Reumatologia· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methotrexate treatment for rheumatoid arthritis in Poland: Retrospective analysis of patients in routine clinical practice.
Jerzy Świerkot, Bogdan Batko, Piotr Wiland, Mariusz Jędrzejewski, Marcin Stajszczyk

Reumatologia· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Bisphosphonates in the treatment of multiple myeloma].
Marcin Stajszczyk

Przegl Lek· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Role of receptor activator of nuclear factor kappa B (RANK), its ligand (RANK-L) and osteoprotegerin (OPG) in bone metabolism].
Marcin Stajszczyk

Pol Arch Med Wewn· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Inhibitors of HMG-CoA reductase in prevention of osteoporosis and bone fractures. Similar mechanism of action of statins and bisphosphonates].
Marcin Stajszczyk, Joanna Mykała-Cieśla

Pol Arch Med Wewn· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis